Source: PLOS ONE. Unidade: FMRP
Subjects: DOENÇAS PARASITÁRIAS, TRYPANOSOMA CRUZI, PROSTAGLANDINAS, DOENÇA DE CHAGAS, CITOCINAS, MORTALIDADE, MODELOS ANIMAIS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUKHERJEE, Shankar et al. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas Disease. PLOS ONE, v. 6, n. 2, p. 1-10, 2011Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0016959. Acesso em: 07 nov. 2024.APA
Mukherjee, S., Machado, F. S., Huang, H., Oz, H. S., Jelicks, L. A., Prado, C. M., et al. (2011). Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas Disease. PLOS ONE, 6( 2), 1-10. doi:10.1371/journal.pone.0016959NLM
Mukherjee S, Machado FS, Huang H, Oz HS, Jelicks LA, Prado CM, Koba W, Fine EJ, Zhao D, Factor SM, Collado JE, Weiss LM, Tanowitz HB, Ashton AW. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas Disease [Internet]. PLOS ONE. 2011 ; 6( 2): 1-10.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1371/journal.pone.0016959Vancouver
Mukherjee S, Machado FS, Huang H, Oz HS, Jelicks LA, Prado CM, Koba W, Fine EJ, Zhao D, Factor SM, Collado JE, Weiss LM, Tanowitz HB, Ashton AW. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas Disease [Internet]. PLOS ONE. 2011 ; 6( 2): 1-10.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1371/journal.pone.0016959